Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCL for Keratectasia in Norway
NCT00435799Phase 3Unknown
- Sponsor
- Ullevål University Hospital
- Start
- Feb 2007
- Primary completion
- Jan 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of riboflavin in keratoconus, sponsored by Ullevål University Hospital. Status: unknown.
02
Drugs
riboflavin
03
Conditions
keratoconus
Beyond the preview
Go deeper on NCT00435799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435799.